Jingjiahang completed an angel round of financing worth tens of millions of yuan.

36Kr learned that recently, Hangzhou Jingjiahang Biomedical Technology Co., Ltd. completed an angel - round financing of tens of millions of RMB. This round of financing was led by Hangshi Asset Management, with Zhengjing Capital and Binjiang Wulingwuling participating as follow - on investors. Gelu Capital served as the financial advisor. The funds raised will be mainly used for the pre - clinical and early - stage clinical development of the company's existing pipelines.